Keyphrases
COVID-19
100%
Tuberculosis
64%
Mycobacterium Tuberculosis (M. tb)
63%
Guinea pig
60%
Ferret
48%
Cynomolgus Macaque
46%
Infection Model
40%
Rhesus Macaque
40%
Lung
39%
Syrian Hamster
36%
Ferret Model
35%
Aerosol
33%
Challenge Model
30%
Virus
29%
Guinea pig Model
27%
Nonhuman Primate
27%
Vaccination
26%
Aerosol Challenge
24%
Immunogenicity
24%
Vaccine Candidate
22%
Protective Immunity
21%
Intranasal Route
21%
DNA Vaccine
21%
Ebola Virus
21%
Syrian Hamster Model
20%
Immune Response
20%
Aerosolized
19%
Disease Progression
18%
BCG Vaccine
18%
High Dose
17%
Macaque
17%
Viral Shedding
17%
Spleen
17%
SARS-CoV-2 Challenge
16%
Protective Effect
16%
Upper Respiratory Tract
16%
Clinical Signs
16%
Hamster
15%
Variable number Tandem Repeat
15%
Balb C Mice
15%
Klebsiella Pneumoniae (K. pneumoniae)
14%
Monkeypox Virus
14%
Influenza
14%
Heterosubtypic
14%
Burkholderia Pseudomallei
14%
Ovine
14%
Recombinant
14%
Murine Model
14%
Influenza-like Illness
14%
Immunoglobulin Therapy
14%
F(ab')2 Fragment
14%
ESAT-6
14%
T Cells
14%
BCG Revaccination
14%
Mouse Strain
14%
Guinea
14%
Viral Genome
14%
Virulence
13%
Protective Efficacy
13%
Weight Loss
13%
Intranasal
13%
Hamster Model
13%
Antigen 85B
13%
Omicron Variant
12%
Vaccine Effectiveness
12%
Mycobacterium
12%
Viral
12%
Interferon-γ
12%
Neutralizing Antibodies
12%
Ebola Outbreak
12%
SARS-CoV-2 Infection
11%
Aerosol Model
11%
Protection Level
11%
Response to Infection
11%
Immune System
11%
Melioidosis
10%
Virus Neutralization
10%
Lung Pathology
10%
Pathogenicity
10%
Ebola Virus Infection
10%
Disease Burden
10%
Disease Severity
10%
Virus Shedding
9%
Viral Load
9%
Bacillus Anthracis
9%
C57BL
9%
Vaccine Response
9%
Medical Countermeasures
9%
Pseudomallei
9%
Challenge Routes
9%
Virus Challenge
9%
Influenza Virus
9%
Nucleoprotein
9%
Ebola Virus Disease
9%
COVID-19 Pandemic
8%
Virus Diseases
8%
Bacillus
8%
Ag85B
8%
Inhalation Anthrax
8%
Disease Pathogenesis
8%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
94%
Guinea Pig
53%
Mustela Putorius Furo
52%
Virus
44%
Macaca fascicularis
39%
Mycobacterium Bovis BCG
36%
Syrian Hamster
36%
Rhesus Monkey
33%
Mycobacterium Tuberculosis
32%
Hamster Model
30%
Ebola Virus
29%
Immune Response
28%
COVID-19
26%
Viral Disease
26%
Influenza
23%
T Cell
22%
Viral Shedding
22%
Immunogenicity
20%
Macaca
20%
Bagg Albino Mouse
16%
Spike
16%
Omicron Coronavirus Variant
16%
Tandem Repeat
15%
Viral Load
14%
Monkeypox Virus
14%
Klebsiella pneumoniae
14%
Guinea Pig Model
14%
Immunotherapy
14%
C57BL 6 Mouse
14%
Mouse Strain
14%
Pharmacokinetics
14%
Upper Respiratory Tract
13%
Drug Megadose
12%
Mycobacteria
12%
Pathogenicity
12%
Interferon Gamma
11%
Influenza A Virus (H1N1)
11%
Low Drug Dose
11%
Influenza A Virus (H3N2)
11%
Bacteriophage
10%
Mouse Model
10%
Immune System
9%
Plasmid
9%
Adoptive Immunity
9%
Wild Type
9%
Infectious Agent
9%
Cell Population
9%
Influenza Virus
9%
Virus Genome
9%
Influenzavirus A
8%
Immunocompetent Cell
8%
Zoonotic
8%
Inactivated Vaccine
8%
Lymphocyte
8%
Nucleoprotein
8%
Monkeypox
7%
BCG Vaccine
7%
Tetanus Vaccine
7%
Magnetic Resonance Imaging
7%
Long Term Survival
7%
Agonist
7%
Lesion Volume
7%
Acinetobacter Baumannii
7%
Influenza Vaccine
7%
Lipoarabinomannan
7%
Gene Expression
7%
Single-Domain Antibody
7%
Smallpox Vaccine
7%
Sulfur Dioxide
7%
Modified Vaccinia Ankara
7%
Microdialysis
7%
Methicillin-Resistant Staphylococcus Aureus
7%
Rift Valley Fever Virus
7%
TLR2
7%
Inoculum
7%
Virulence Plasmid
7%
Conjugate
7%
Burkholderia pseudomallei
7%
Lassa Virus
7%
Cross Protection
7%
Host Immune Response
7%
Monoclonal Antibody
7%
DNA Virus
7%
interferon
7%
Chikungunya Virus
7%
Glutamic Acid
7%
Antibody Affinity
7%
Nipah virus
7%
Population Dynamics
7%
Henipavirus
7%
DNA Immunization
7%
Titer
7%
Filovirus
7%
Neutralizing Antibody
6%
ELISA
6%
T-Helper Cell
5%
Chemostat
5%
Hemorrhagic Fever
5%
Antibody Titer
5%